Skip to main

Hepatology and Liver Transplantation: Today and Tomorrow 2025

Hepatology and Liver Transplantation: Today and Tomorrow 2025

Hosted by the Mayo Clinic. This course covers new developments in hepatology and novel approaches to the management of liver diseases. This course was endorsed by the American Society of Transplantation.

  • 8:00 AM - 5:00 PM EDT
  • In-person (Orlando, FL) and Virtual (Livestream)

This course provides attendees with relevant information regarding new developments in hepatology, and novel approaches to the management of liver diseases that can be readily integrated into daily clinical practice. Nationally and internationally renowned experts present new findings in a case-based format that highlights the management of common, as well as unique and complex liver diseases and liver cancers.

Target Audience:
This course is designed for gastroenterologists, hepatologists, primary care providers, nurse practitioners and physician assistants in GI and endocrinology. Primary care providers may also find this course beneficial.

Learning Objectives:
Upon completion of this activity, participants should be able to:

  • Review the latest approaches to manage patients with advanced liver disease and acute on chronic liver failure.
  • Review newly approved treatments in cholestatic liver disease.
  • Review the evaluation and management of patients with metabolic dysfunction associated steatotic liver disease.
  • Review new innovations in liver transplantation and how they are impacting patients awaiting transplant.
  • Assess the latest diagnostic and therapeutic advances in liver cancer.
  • Identify the role of palliative care in managing patients with end-stage liver disease. 

This course was endorsed by the American Society of Transplantation.

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi